🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Kathryn Mngadi

Kathryn Mngadi

University of South Africa

ORCID: 0000-0002-7847-3671

Also affiliated with Aurum Institute

Immunology and MicrobiologyMedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study”.

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet(2022)10.1016/s0140-6736(22)00007-1

N/A

4.4DataRank · unranked

85 citations

Nigel Garrett, Ameena Goga, Lara Fairall, Tarylee Reddy, Nonhlanhla Yende-Zuma +76 more

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Clinical Infectious Diseases(2024)10.1093/cid/ciae010

N/A

4.1DataRank · unranked

164 citations

Alberto Papi, Eugene Athan, Robert G. Feldman, Joanne M. Langley, Dong‐Gun Lee +95 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x

N/A

1.3DataRank · unranked

40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(25)00048-7

N/A

1.2DataRank · unranked

58 citations

Alberto Papi, Eugene Athan, Robert G. Feldman, Joanne M. Langley, Dong‐Gun Lee +95 more

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054

N/A

0.269DataRank · unranked

5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Emerging Microbes & Infections(2025)10.1080/22221751.2025.2485317

N/A

0.260DataRank · unranked

4 citations

Shuying Sue Li, Elena Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp +34 more

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319

N/A

0.108DataRank · unranked

1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46

N/A

0DataRank · unranked

0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

EBioMedicine(2021)10.1016/j.ebiom.2020.103203

N/A

0DataRank · unranked

29 citations

Logashvari Naidoo, Lily Zhang, Lindsay N. Carpp, Erika Rudnicki, April K. Randhawa +18 more

High Asymptomatic Carriage With the Omicron Variant in South Africa

Clinical Infectious Diseases(2022)10.1093/cid/ciac237

N/A

0DataRank · unranked

81 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +85 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/f8gd-ra57

N/A

0DataRank · unranked

0 citations

Paula González, Kathryn Mngadi, John R. Mascola, L. Naidoo, Peter B. Gilbert +18 more

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

EBioMedicine(2024)10.1016/j.ebiom.2024.105320

N/A

0DataRank · unranked

16 citations

Janine van Duijn, One Dintwe, Jack Heptinstall, Randy I. Burnham, Sheetal Sawant +93 more